Tag: Eulexin

The Food and Drug Administration (FDA) received reports of 20 deaths linked to flutamide-induced hepatotoxicity within the first five years of its approval. This severe risk is the primary reason behind the strategic phasing out of the drug, explaining **why was flutamide discontinued** from widespread clinical use.

First approved by the FDA in 1989, flutamide was the first nonsteroidal antiandrogen on the market, offering a new approach to hormone therapy. As a potent inhibitor of male hormones, understanding what is flutamide used for involves exploring its primary role in cancer treatment, as well as its historical application for androgen-dependent conditions in women.